Sungchae Hong
Busan, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Lipophilic modification enhances anti-colitic properties of rosmarinic acid by potentiating its HIF-prolyl hydroxylases inhibitory activity.
Journal: European journal of pharmacology
Published: September 11, 2014
N-(2-Mercaptopropionyl)-glycine, a diffusible antioxidant, activates HIF-1 by inhibiting HIF prolyl hydroxylase-2: implication in amelioration of rat colitis by the antioxidant.
Journal: Biochemical and biophysical research communications
Published: December 06, 2013
Colon-targeted celecoxib ameliorates TNBS-induced rat colitis: a potential pharmacologic mechanism and therapeutic advantages.
Journal: European journal of pharmacology
Published: September 18, 2013
Caffeic acid phenethyl ester activation of Nrf2 pathway is enhanced under oxidative state: structural analysis and potential as a pathologically targeted therapeutic agent in treatment of colonic inflammation.
Journal: Free radical biology & medicine
Published: January 18, 2013
Piceatannol, a hydroxystilbene natural product, stabilizes HIF-1α protein by inhibiting HIF prolyl hydroxylase.
Journal: European journal of pharmacology
Published: August 17, 2012
Colon-targeted cell-permeable NFκB inhibitory peptide is orally active against experimental colitis.
Colon-targeted cell-permeable NFκB inhibitory peptide is orally active against experimental colitis.
Journal: Molecular pharmaceutics
Published: March 21, 2012
Susceptibility of glucocorticoids to colonic metabolism and pharmacologic intervention in the metabolism: implication for therapeutic activity of colon-specific glucocorticoid 21-sulfate sodium at the target site.
Journal: The Journal of pharmacy and pharmacology
Published: December 14, 2011
Showing 1-8 of 8
Last Updated: 09/26/2026